Daniel Zingg
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
- Cutaneous Melanoma Detection and Management
- Molecular Biology top 10%
- Melanoma and MAPK Pathways
- Epigenetics and DNA Methylation
- Developmental Biology and Gene Regulation
- Chromatin Remodeling and Cancer
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 8
- Melanoma and MAPK Pathways 6
- Fibroblast Growth Factor Research 3
- Epigenetics and DNA Methylation 2
- Oncology 5
- Cancer Immunotherapy and Biomarkers 3
- Cancer Cells and Metastasis 2
- Co-authors
- Lukas Sommer (10 shared papers)Jessica Häusel (5 shared papers)Onur Boyman (3 shared papers)Natalia Arenas-Ramirez (3 shared papers)Reinhard Dummer (7 shared papers)Mitchell Paul Levesque (6 shared papers)Phil Fang Cheng (5 shared papers)Rodney Alexander Rosalia (1 shared paper)
- Journals
- Cancer Research (3 papers)Journal of Bacteriology (2 papers)Journal of Clinical Investigation (1 paper)Science Translational Medicine (1 paper)Nature Communications (1 paper)
- Partner nations
- SwitzerlandGermanyNetherlands
In The Last Decade
Daniel Zingg
26 papers receiving 1.8k citations
Peers
Comparison fields: 5 of 83
- Oncology 523
- Molecular Biology 829
- Cancer Research 153
- Immunology 122
- Cell Biology 74
Countries citing papers authored by Daniel Zingg
This map shows the geographic impact of Daniel Zingg's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daniel Zingg with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daniel Zingg more than expected).
Fields of papers citing papers by Daniel Zingg
This network shows the impact of papers produced by Daniel Zingg. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daniel Zingg. The network helps show where Daniel Zingg may publish in the future.
Co-authors
The 25 scholars most cited alongside Daniel Zingg, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 281 | |
| 2 | 2017 | 275 | |
| 3 | 2012 | 216 | |
| 4 | 2017 | 142 | |
| 5 | 2016 | 115 | |
| 6 | 2018 | 111 | |
| 7 | 2022 | 86 | |
| 8 | 2015 | 83 | |
| 9 | 2015 | 74 | |
| 10 | The phosphatidylinositide 3'-kinase/Akt survival pathway is a target for the anticancer and radiosensitizing agent PKC412, an inhibitor of protein kinase C. | 2001 | 64 |
| 11 | 2004 | 64 | |
| 12 | 2019 | 54 | |
| 13 | 2004 | 49 | |
| 14 | 2019 | 42 | |
| 15 | 2001 | 41 | |
| 16 | 2007 | 41 | |
| 17 | 2011 | 20 | |
| 18 | 2023 | 15 | |
| 19 | 2020 | 13 | |
| 20 | 2004 | 12 |
About Daniel Zingg
Daniel Zingg is a scholar working on Molecular Biology, Oncology, Cell Biology, Immunology and Genetics, having authored 29 papers that have together received 1.8k indexed citations. Recurring topics across this work include PI3K/AKT/mTOR signaling in cancer (8 papers), Melanoma and MAPK Pathways (6 papers), Cancer Immunotherapy and Biomarkers (3 papers), Fibroblast Growth Factor Research (3 papers), Cancer Cells and Metastasis (2 papers), melanin and skin pigmentation (2 papers), Epigenetics and DNA Methylation (2 papers) and Diagnosis and Treatment of Venous Diseases (2 papers). The work is most often cited by research in Oncology (523 citations), Molecular Biology (829 citations), Cancer Research (153 citations), Immunology (122 citations) and Cell Biology (74 citations). Daniel Zingg has collaborated with scholars based in Switzerland, Germany and Netherlands. Frequent co-authors include Lukas Sommer, Jessica Häusel, Onur Boyman, Natalia Arenas-Ramirez, Reinhard Dummer, Mitchell Paul Levesque, Phil Fang Cheng, Rodney Alexander Rosalia, Dilara Şahin and Stephan B. Bodis. Their work appears in journals such as Cancer Research, Journal of Bacteriology, Journal of Clinical Investigation, Science Translational Medicine and Nature Communications.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.